Interventions for valvular disease Transcatheter mitral valve replacement: factors associated with screening success and failure Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T December 6, 2019 | 10.4244/EIJ-D-19-00444
Interventions for valvular disease Transcatheter Mitral Valve Replacement: Factors Associated with Screening Success and Failure. Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T August 27, 2019 | 10.4244/EIJ-D-19-00444
Improving our knowledge about a new plug-based vascular closure device Tchétché D May 20, 2019 | 10.4244/EIJV15I1A4
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy Lansky A, Ghare M, Tchétché D, Baumbach A September 7, 2018 | 10.4244/EIJ-D-18-00454
Interventions for valvular disease Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J August 3, 2018 | 10.4244/EIJ-D-17-01040
Interventions for valvular disease Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K September 20, 2017 | 10.4244/EIJ-D-16-01025
Interventions for valvular disease The SURTAVI study: TAVI for patients with intermediate risk Jones D, Tchétché D, Forrest J, Hellig F, Lansky A, Moat N August 4, 2017 | 10.4244/EIJV13I5A97
Interventions for valvular disease How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm? Rahhab Z, Raa S, van der Ploeg N, Van Mieghem N, Verhagen H, de Jaegere P, Arsalan M, Kim W, Walther T, Tchétché D July 20, 2017 | 10.4244/EIJ-D-16-00461
Interventions for valvular disease Annulus rupture post transcatheter aortic valve implantation complicated by a giant pseudoaneurysm Thimon T, Molina-Martin de Nicolas J, Lapeyre M, Tchétché D February 3, 2017 | 10.4244/EIJ-D-16-00347
Interventions for valvular disease A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis Naber C, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner M, Latib A, De Marco F, Kische S December 9, 2016 | 10.4244/EIJ-D-15-00511
Interventions for valvular disease Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy Giustino G, van der Boon R, Molina-Martin de Nicolas J, Dumonteil N, Chieffo A, de Jaegere P, Tchétché D, Marcheix B, Millischer D, Cassagneau R, Carrié D, Van Mieghem N, Colombo A October 20, 2016 | 10.4244/EIJV12I9A192
Interventions for valvular disease Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves Simonato M, Azadani A, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera H, Tchétché D, Moat N, Teles R, Petronio A, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D September 18, 2016 | 10.4244/EIJV12I7A149
Interventions for valvular disease TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery Van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N September 18, 2016 | 10.4244/EIJV12SYA6
Interventions for valvular disease Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein AP, de Jaegere P, Tchétché D February 12, 2016 | 10.4244/EIJV11I10A253
Interventions for valvular disease Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report Molina-Martin de Nicolas J, Tchétché D, Farah B February 12, 2016 | 10.4244/EIJV11I11A255
New-generation TAVI devices: description and specifications Tchétché D, Van Mieghem N September 27, 2014 | 10.4244/EIJV10SUA13
How should I treat a patient with symptomatic severe aortic stenosis and a 23 mm aortic annulus who is referred for transcatheter aortic valve replacement using the CoreValve prosthesis? Ko B, Antonis P, Meredith I, Tchétché D, Eggebrecht H, Zierer A, Doss M February 22, 2013 | 10.4244/EIJV8I10A186
Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system Tchétché D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J September 28, 2012 | 10.4244/EIJV8I5A86
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019